Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 511 AL 525

Histone deacetylase's regulates Tau function in Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:339-361. doi: 10.1016/bs.apcsb.2024.09.008. Epub 2024 Oct 7.

Nuclear transport protein suppresses Tau neurodegeneration

Chinnathambi S, Adithyan A, Suresh S, Velmurugan G, Chandrashekar M, Sahu S, Mishra M.

Adv Protein Chem Struct Biol. 2025;143:363-385. doi: 10.1016/bs.apcsb.2024.07.001. Epub 2024 Jul 26.

Nuclear podosomes regulates cellular migration in Tau and Alzheimer's disease

Qureshi T, Chandrashekar M, Ananthanarayana V, Kumarappan M, Rangappa N, Velmurugan G, Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:411-426. doi: 10.1016/bs.apcsb.2024.09.009. Epub 2024 Oct 2.

Communicating scientific evidence: drugs for Alzheimer's disease as a case study

Kepp KP, Høilund-Carlsen PF, Cristea IA, Cumming RG, Daly T, Emilsson L, Flacco ME, Hemkens LG, Janiaud P, Johnsen KB, Lallukka T, Muka T, Naudet F, Revheim MR, Squitti R, Thambisetty M.

Curr Med Res Opin. 2025 Feb;41(2):347-354. doi: 10.1080/03007995.2025.2458530. Epub 2025 Feb 5.

Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies

Miliotou AN, Kotsoni A, Zacharia LC.

Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128.

Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications

He S, Xu Z, Han X.

Mol Neurodegener. 2025 Jan 27;20(1):11. doi: 10.1186/s13024-025-00803-6.

Cell-specific transcriptional signatures of vascular cells in Alzheimer's disease: perspectives, pathways, and therapeutic directions

Chaudhuri S, Cho M, Stumpff JC, Bice PJ, İş Ö, Ertekin-Taner N, Saykin AJ, Nho K.

Mol Neurodegener. 2025 Jan 29;20(1):12. doi: 10.1186/s13024-025-00798-0.

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease

Singh S, Singh RK.

Mol Biol Rep. 2025 Jan 29;52(1):173. doi: 10.1007/s11033-025-10297-6.

Senescent microglia: The hidden culprits accelerating Alzheimer's disease

Li W, Yong-Yan X, Jia-Xin M, Shu-Chao G, Li-Ping H.

Brain Res. 2025 Mar 15;1851:149480. doi: 10.1016/j.brainres.2025.149480. Epub 2025 Jan 28.

Histopathological changes of nervous tissue in women over 60 years of age with Alzheimer's disease and their relationship with menopause

Tarrá Marrugo AD.

Rev Esp Patol. 2025 Jan-Mar;58(1):100800. doi: 10.1016/j.patol.2024.100800. Epub 2025 Jan 30.

Non-coding RNAs in the pathogenesis of Alzheimer's disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation

Jiménez-Ramírez IA, Castaño E.

Mol Biol Rep. 2025 Jan 31;52(1):183. doi: 10.1007/s11033-025-10284-x.

Brain interleukins and Alzheimer's disease

Abdelhamed HG, Hassan AA, Sakraan AA, Al-Deeb RT, Mousa DM, Aboul Ezz HS, Noor NA, Khadrawy YA, Radwan NM.

Metab Brain Dis. 2025 Feb 1;40(2):116. doi: 10.1007/s11011-025-01538-5.

Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease

Alarcón-Espósito J, Nagiri RK, Gan L, Sinha SC.

Neurotherapeutics. 2025 Apr;22(3):e00536. doi: 10.1016/j.neurot.2025.e00536. Epub 2025 Jan 31.

The role of the gut microbiome in Alzheimer's disease pathophysiology

Borrego-Ruiz A, Borrego JJ.

Curr Opin Neurol. 2025 Apr 1;38(2):157-162. doi: 10.1097/WCO.0000000000001352. Epub 2025 Feb 7.

Treatments of psychosomatic symptoms in Alzheimer's disease: a scoping review of the potential therapeutic effects of essential oils

Abdulghani MF, Barzegari R, Almagharbeh WT, Yazdani Z, Amandadi Ghotbabadi A, Seyed Bagheri SH, Alnaiem M, Dehghan M.

Psychogeriatrics. 2025 Mar;25(2):e70007. doi: 10.1111/psyg.70007.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias